Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Total Debt (2020 - 2023)

Historic Total Debt for Silo Pharma (SILO) over the last 4 years, with Q1 2023 value amounting to $660279.0.

  • Silo Pharma's Total Debt rose 91833.62% to $660279.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $660279.0, marking a year-over-year increase of 91833.62%. This contributed to the annual value of $364216.0 for FY2022, which is 1285.39% down from last year.
  • Per Silo Pharma's latest filing, its Total Debt stood at $660279.0 for Q1 2023, which was up 91833.62% from $364216.0 recorded in Q4 2022.
  • In the past 5 years, Silo Pharma's Total Debt registered a high of $660279.0 during Q1 2023, and its lowest value of $3429.0 during Q1 2021.
  • In the last 4 years, Silo Pharma's Total Debt had a median value of $52829.0 in 2022 and averaged $144975.1.
  • In the last 5 years, Silo Pharma's Total Debt skyrocketed by 974307.58% in 2021 and then tumbled by 7718.96% in 2022.
  • Silo Pharma's Total Debt (Quarter) stood at $4246.0 in 2020, then surged by 9743.08% to $417937.0 in 2021, then dropped by 12.85% to $364216.0 in 2022, then surged by 81.29% to $660279.0 in 2023.
  • Its Total Debt was $660279.0 in Q1 2023, compared to $364216.0 in Q4 2022 and $16447.0 in Q3 2022.